Syros Pharms

SYRS NASDAQ
6.74
-0.10
-1.39%
交易中 13:57 06/24 EDT
开盘
6.81
昨收
6.83
最高
7.11
最低
6.59
成交量
4.51万
成交均量(3M)
16.34万
52周最高
13.18
52周最低
5.17
换手率
0.11%
市值
2.86亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Syros Pharms SYRS股票价格,Syros Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid (DNA) in human disease tissue to identify and drug targets linked to genomically defined patient populations. The Company is focused on developing treatments for cancer and immune-mediated diseases and is building a pipeline of gene control medicines. The Company's drug programs include SY-1425 (retinoic acid receptor alpha (RARa) agonist) and SY-1365 (cyclin-dependent kinase 7 (CDK7) inhibitor). SY-1425 (tamibarotene) is an oral, potent and selective agonist, or activator, of the transcription factor RARa. SY-1365 is a small molecule inhibitor of the transcriptional kinase known as CDK7. The Company is using its platform to analyze gene expression programs across additional cancers, solid tumors, inflammatory diseases and other diseases to find optimal points of therapeutic intervention in patients.
展开 >

最近浏览

名称
价格
涨跌幅